NICE calls for further research on tinnitus management
Healthcare professionals should develop a management plan with the patient
Read More
Author: Selina McKee
Hospital admissions increase 28% in ten years
The figures should serve as a “wake-up call’, says the BMJ.
Read More
Bluebird reveals positive gene therapy data
The therapy targets cerebral adrenoleukodystrophy (CALD), the most severe manifestation of adrenoleukodystrophy (ALD), a rare metabolic disorder.
Read More
Janssen hands back rights to Hanmi’s diabetes/obesity drug
The drug “fell short” of Janssen’s expectations on blood glucose control in obese patients
Read More
GSK launches PhIII programme for otilimab in RA
The Phase III clinical programme is the first in RA to include head-to-head comparisons of otilimab with current treatments across all pivotal studies
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
